Analysts Offer Insights on Real Estate Companies: Regency Centers (REG), Sabra Healthcare REIT (SBRA) and SBA Communications (SBAC)
Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Regency Centers (REG), Sabra Healthcare REIT (SBRA) and SBA Communications (SBAC).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Regency Centers (REG)
Truist Financial analyst Michael Lewis maintained a Buy rating on Regency Centers today. The company’s shares closed last Thursday at $78.78.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Regency Centers with a $83.17 average price target, representing a 4.8% upside. In a report issued on April 21, Morgan Stanley also maintained a Buy rating on the stock with a $88.00 price target.
See the top stocks recommended by analysts >>
Sabra Healthcare REIT (SBRA)
Scotiabank analyst Nicholas Yulico maintained a Hold rating on Sabra Healthcare REIT today and set a price target of $21.00. The company’s shares closed last Thursday at $20.51.
According to TipRanks.com, Yulico is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $22.14 average price target, representing an 8.8% upside. In a report released today, TipRanks – OpenAI also downgraded the stock to Hold with a $22.00 price target.
SBA Communications (SBAC)
Truist Financial analyst Matthew Niknam maintained a Buy rating on SBA Communications today. The company’s shares closed last Thursday at $213.84.
According to TipRanks.com, Niknam is a 4-star analyst with an average return of
SBA Communications has an analyst consensus of Moderate Buy, with a price target consensus of $224.42, which is a 3.9% upside from current levels. In a report released today, TipRanks – PerPlexity also upgraded the stock to Buy with a $243.00 price target.
Read More on REG:
Disclaimer & DisclosureReport an Issue
- Regency Centers: Buy Rating Reaffirmed on Strong Pipeline and Earnings Visibility; $88 Price Target Maintained
- Regency Centers Delivers Strong Q1 Results and Outlook
- Regency Centers Reports Strong Q1 2026 Earnings and Outlook
- Regency Centers reports Q1 FFO $1.20, consensus $1.20
- Regency Centers affirms FY26 FFO view $4.83-$4.87, consensus $4.83
